Amy Flynt
Impact in
-
- Chemokine receptors and signaling
- Cancer Cells and Metastasis
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 5
- Lung Cancer Research Studies 4
- Chemokine receptors and signaling 4
-
- Cancer Mechanisms and Therapy 3
- Co-authors
- John Polzer (5 shared papers)John R. Stille (6 shared papers)Stephanie Roberson (6 shared papers)Oday Hamid (5 shared papers)Eyas Raddad (5 shared papers)Michael McCleod (3 shared papers)David R. Spigel (3 shared papers)Ravi Salgia (3 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Antiviral Therapy (1 paper)Journal of Orthopaedic Trauma (1 paper)Journal of the Renin-Angiotensin-Aldosterone System (1 paper)Medicine (1 paper)
- Partner nations
- United StatesBelgiumHong Kong
In The Last Decade
Amy Flynt
15 papers receiving 385 citations
Peers
Comparison fields: 5 of 63
- Oncology 126
- Immunology 73
- Microbiology 19
- Epidemiology 97
- Endocrinology, Diabetes and Metabolism 38
Countries citing papers authored by Amy Flynt
This map shows the geographic impact of Amy Flynt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Flynt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Flynt more than expected).
Fields of papers citing papers by Amy Flynt
This network shows the impact of papers produced by Amy Flynt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Flynt. The network helps show where Amy Flynt may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Flynt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 65 | |
| 2 | 2012 | 58 | |
| 3 | 2017 | 58 | |
| 4 | 2016 | 56 | |
| 5 | 2022 | 49 | |
| 6 | 2017 | 37 | |
| 7 | 2017 | 35 | |
| 8 | 2020 | 12 | |
| 9 | 2012 | 8 | |
| 10 | 2015 | 7 | |
| 11 | 2018 | 4 | |
| 12 | 2015 | 3 | |
| 13 | 2017 | 2 | |
| 14 | 2022 | 1 | |
| 15 | 2015 | 1 |
About Amy Flynt
Amy Flynt is a scholar working on Oncology, Pathology and Forensic Medicine, Epidemiology, Molecular Biology and Nephrology, having authored 15 papers that have together received 396 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), Chemokine receptors and signaling (4 papers), Cancer Mechanisms and Therapy (3 papers), Influenza Virus Research Studies (2 papers), Renal cell carcinoma treatment (1 paper), Chronic Kidney Disease and Diabetes (1 paper), Muscle Physiology and Disorders (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Oncology (126 citations), Immunology (73 citations), Microbiology (19 citations), Epidemiology (97 citations) and Endocrinology, Diabetes and Metabolism (38 citations). Amy Flynt has collaborated with scholars based in United States, Belgium and Hong Kong. Frequent co-authors include John Polzer, John R. Stille, Stephanie Roberson, Oday Hamid, Eyas Raddad, Michael McCleod, David R. Spigel, Ravi Salgia, Michael G. Ison and Thomas Simon. Their work appears in journals such as Journal of Clinical Oncology, Antiviral Therapy, Journal of Orthopaedic Trauma, Journal of the Renin-Angiotensin-Aldosterone System and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.